CervoMed Inc (CRVO) Stock Price

2.55 ▲ +0.11 (+4.51%)
Open: 2.53 Vol: 0 Day's range: 2.53 - 2.58 Sep 17, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CRVO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.57▼ 2.56▼ 2.55▼ 2.51▲ 2.58▼
MA10 2.56▼ 2.52▲ 2.50▲ 2.52▲ 2.68▼
MA20 2.51▲ 2.49▲ 2.49▲ 2.57▼ 3.03▼
MA50 2.48▲ 2.50▲ 2.51▲ 2.75▼ 4.89▼
MA100 2.51▲ 2.52▲ 2.55▲ 3.06▼ 6.16▼
MA200 2.52▲ 2.57▼ 2.66▼ 4.38▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.006▲ 0.014▲ 0.014▲ 0.005▲ 0.074▲
RSI 60.609▲ 59.661▲ 57.886▲ 45.947▼ 37.206▼
STOCH 79.167     92.939▲ 92.939▲ 36.341     11.410▼
WILL %R -18.750▲ -17.143▲ -17.143▲ -44.444     -97.227▼
CCI 24.261     63.340     79.272     11.398     -73.296    
Latest Filters Detected On CRVO
▲ MACD $CRVO MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $CRVO Price Crossed Above MA(13) Set Alert
MA $CRVO Price Crossed Above MA(7) Set Alert
▲ GAP $CRVO Open Gap Up %3 Set Alert
▲ GAP $CRVO Open Gap Up %2 Set Alert
CDL $CRVO Shooting Star Candlestick Pattern Detected Set Alert
CervoMed Inc News
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late ...
Thursday, September 10, 2026 04:29 AM
International Society of Frontotemporal Dementias (ISFTD) Annual Meeting nfvPPA, the type of frontotemporal dementia (FTD) most commonly associated with tau pathology, currently has no approved ...
CervoMed to Participate in September Investor Conferences
Tuesday, September 08, 2026 12:31 AM
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders ("CervoMed" or the "Company"), ...
CervoMed Analyst Price Targets
Tuesday, August 11, 2026 05:00 PM
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates CervoMed (NASDAQ:CRVO) with a Buy and maintains $25 price target. Canaccord Genuity analyst Sumant Kulkarni maintains CervoMed (NASDAQ:CRVO) ...
CRVO historical stock data
date open high low close volume
17/09/26 2.53 2.58 2.53 2.55 82,914
16/09/26 2.45 2.5192 2.40 2.44 100,328
15/09/26 2.53 2.53 2.43 2.45 106,984
14/09/26 2.54 2.58 2.49 2.53 128,295
11/09/26 2.54 2.6396 2.50 2.57 234,572
10/09/26 2.50 2.53 2.47 2.48 114,864
09/09/26 2.53 2.54 2.47 2.51 129,973
08/09/26 2.58 2.58 2.4199 2.53 392,643
04/09/26 2.54 2.58 2.52 2.56 108,604
03/09/26 2.66 2.665 2.52 2.54 199,035
Quote Details
52wk Low:2.145
52wk High:10.00
Vol:0
Avg Vol(3m):6.8M
1Y Chng:-70.69%
1M Chng:-7.61%
Add to Watch List
More Information
Index US Composite
Market Cap. 37.04M